Navigation Links
InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results
Date:9/17/2013

owth.

The loss from operations for the fiscal year ended June 30, 2013 was $15.1 million, a decrease of 14.1% compared to $17.5 million for the same period in 2012.

The net loss for the fiscal year ended June 30, 2013 totaled $29.3 million, or $1.39 per basic and diluted share, an increase of 66.3% compared to a net loss of $17.6 million, or $1.04 per basic and diluted share in the period in 2012. The increase in net loss resulted primarily from an increase of $14.1 million in financial expenses, of which, $13.4 million were non-recurring, non-cash costs associated with the Company's convertible debt.

Non-GAAP net loss for the fiscal year ended June 30, 2013 was $11.0 million, or $0.53 per share, compared to $7.4 million, or $0.44 per share, for the same period in 2012.  The non-GAAP net loss for fiscal year 2013 primarily excludes the $13.4 million non-recurring, non-cash costs associated with the Company's convertible debt, and $3.8 million in share-based compensation.  The non-GAAP net loss for fiscal year 2012 primarily excludes $10.6 million in share-based compensation.

Cash and Cash EquivalentsAt June 30, 2013, cash and cash equivalents were $14.8 million, an increase of 44.1% compared to $10.3 million at June 30, 2012. The Company's cash increased mainly due to the April 2013 capital raise with net proceeds of $14.1 million.

Change to Fiscal Year The Company announced today that it will be changing its fiscal reporting year end from June 30th to December 31st.  It will run a transitional six-month fiscal year from July 1st to December 31st, 2013.  Management believes that this change will allow the Company to better align its financial periods and annual budget planning with its business cycle, as well as assist the investment community with following its progress moving forward. 

Investor Conference Call  The Company will host a conference ca
'/>"/>

SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Two ... increasing in applications as their effectiveness is ... Kalorama Information.  Kalorama Information says that while ... the most powerful tool in proteomic biomarker ... MS) through its traditional techniques has struggled ...
(Date:2/26/2015)... Ill. , Feb. 26, 2015  AbbVie ... 15 abstracts of studies in its neuroscience and ... during the 67 th American Academy of ... , from April 18-25. The accepted abstracts ... DUOPA, in addition to investigational treatments in AbbVie,s ...
(Date:2/26/2015)... 26, 2015  Mail-service and specialty pharmacies will ... and government health plans $23.3 billion over the ... Pharmaceutical Care Management Association (PCMA). "Home ... of the easiest ways to reduce health costs," ... . "Policymakers should resist efforts to restrict these ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
(Date:2/27/2015)... 27, 2015 Legislation passed today ... a pharmacy provision to help prevent inappropriate prescriptions ... counter. The Protecting the Integrity of Medicare Act ... Chairman Kevin Brady (R-TX) and Ranking Member Jim ... prescription drug abuse epidemic and implement the right ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The winter season ... growth and expansion. When mold grows, it can be harmful ... sure to avoid the consequences of mold growth with the ... Island, is offering tips on the best ways to prevent ... season, which makes perfect conditions for mold to thrive. Mold ...
(Date:2/27/2015)... 2015 FACE Skincare~Medical~Wellness, a multiaward-winning ... a unique combination to take fifteen years off ... is a new treatment introduced that is the ... indicated to improve lines and wrinkles on the ... who suffers from the stubborn vertical lines between ...
(Date:2/27/2015)... February 27, 2015 The UC Davis ... expertise have made it a beacon of hope for ... has been acknowledged by the national society committed to ... Huntington’s Disease Society of America — as a Level ... acknowledgement recognizes the center’s service to over 300 families ...
(Date:2/27/2015)... Healthpointe is now performing arthroscopy ... or diseases affecting the elbow , wrist ... throughout Southern California, and are dedicated in providing ... related to the upper extremities. , Dr. ... board-certified and fully trained in treating an array ...
Breaking Medicine News(10 mins):Health News:PCMA Statement on the ‘Protecting the Integrity of Medicare Act’ 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Face Skincare Announces New Combination Therapy 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:Healthpointe is Now Performing Arthroscopic Surgery Techniques for Elbow, Hand and Wrist Injuries and Diseases, such as certain Ganglion Cysts 2
... is available in <A HREF=",http://chinese.eurekalert.org/zh/emb_releases/2009-06/oup-wfc060109.php,">Chinese . ... transform into pluripotent stem cells cells that, like ... type of cell in the body. It is the ... achieved using somatic cells (cells that are not sperm ...
... June 2 Beckman Coulter, Inc. (NYSE: BEC ... simplify, automate, and innovate complex biomedical tests, announces upcoming investor ... http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) , , , ... - The American Association for, ...
... CASHIERS, N.C., June 2 Typical ninth graders are worried about ... friends from middle school, or keeping up with the latest popular ... the next or other mobility issues. But Luis Magana is not ... , Although Magana was diagnosed with brain cancer almost four years ...
... to regain lost trust , TUESDAY, June 2 (HealthDay News) ... criticized for not informing the public about its inner workings, ... study how to be more transparent. , "This is ... make FDA and its processes more transparent to the public," ...
... Guests ... a unique weekend series of special events and seminars with expert panels and educative discussions ... Scottsdale, Ariz. (Vocus) -- ... for the first time ever to offer a weekend retreat focused on health and wellness. ...
... (NMI), a global leader in payment gateway technologies, announced its ... Schaumburg,s Children,s Home & Aid Family Center. , , ... said NMI,s CEO Jim McKenzie. "Children,s Home & Aid is ... chance can benefit," McKenzie added. , ...
Cached Medicine News:Health News:World first: Chinese scientists create pig stem cells 2Health News:World first: Chinese scientists create pig stem cells 3Health News:Upcoming Investor Events at The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition 2Health News:The SCOOTER Store Donates Scooter to North Carolina Student With Brain Cancer 2Health News:The SCOOTER Store Donates Scooter to North Carolina Student With Brain Cancer 3Health News:FDA to Study Ways to Be More Open With Public 2Health News:FDA to Study Ways to Be More Open With Public 3Health News:The Westin Kierland Resort And Mayo Clinic Present "Well Beyond" Weekend 2Health News:The Westin Kierland Resort And Mayo Clinic Present "Well Beyond" Weekend 3Health News:The Westin Kierland Resort And Mayo Clinic Present "Well Beyond" Weekend 4Health News:Network Merchants, Inc (NMI) Founders Donate $50,000 to Schaumburg's Children's Home & Aid 2
The °CureWrap is one-piece garment offers maximum available surface coverage, while avoiding the sterilized fields of operation....
... Antibody (IgG) Test is a semiquantitative enzyme ... significant IgG antibodies to M. pneumoniae between ... test should not be used for specimens ... (IgM) Test and is not intended for ...
... Test is a qualitative enzyme immunoassay ... Epstein-Barr virus capsid antigen (EBV-VCA), Epstein-Barr ... and Toxoplasma. When used in conjunction ... aid in the serodiagnosis of infectious ...
... Test is an enzyme immunoassay ... the presence of antibodies to ... and herpes simplex virus in ... to indicate previous or current ...
Medicine Products: